

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 5.39220663 |
| 2 | pyrimidine nucleobase catabolic process (GO:0006208) | 5.21827007 |
| 3 | nucleobase catabolic process (GO:0046113) | 4.65780837 |
| 4 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.18954163 |
| 5 | cellular potassium ion homeostasis (GO:0030007) | 4.03735411 |
| 6 | neuronal action potential propagation (GO:0019227) | 4.00325295 |
| 7 | neuronal ion channel clustering (GO:0045161) | 3.87105956 |
| 8 | L-amino acid import (GO:0043092) | 3.64376626 |
| 9 | neurotransmitter transport (GO:0006836) | 3.52276548 |
| 10 | layer formation in cerebral cortex (GO:0021819) | 3.50318847 |
| 11 | amino acid import (GO:0043090) | 3.47756496 |
| 12 | sodium ion export (GO:0071436) | 3.47614199 |
| 13 | neuron cell-cell adhesion (GO:0007158) | 3.46069769 |
| 14 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.45278043 |
| 15 | regulation of neurotransmitter levels (GO:0001505) | 3.34736403 |
| 16 | neuron-neuron synaptic transmission (GO:0007270) | 3.33650695 |
| 17 | positive regulation of synapse maturation (GO:0090129) | 3.26273861 |
| 18 | establishment of mitochondrion localization (GO:0051654) | 3.26037551 |
| 19 | positive regulation of dendritic spine development (GO:0060999) | 3.15715381 |
| 20 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.12825430 |
| 21 | neuron recognition (GO:0008038) | 3.11619124 |
| 22 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.09950648 |
| 23 | negative regulation of dendrite development (GO:2000171) | 3.09107578 |
| 24 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.07987238 |
| 25 | dendrite morphogenesis (GO:0048813) | 3.07938336 |
| 26 | detection of calcium ion (GO:0005513) | 3.06530284 |
| 27 | synaptic vesicle maturation (GO:0016188) | 3.05347132 |
| 28 | positive regulation of membrane potential (GO:0045838) | 3.05072309 |
| 29 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.00728413 |
| 30 | potassium ion homeostasis (GO:0055075) | 3.00726002 |
| 31 | regulation of vesicle fusion (GO:0031338) | 3.00233311 |
| 32 | regulation of neurotransmitter secretion (GO:0046928) | 3.00041677 |
| 33 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.98601077 |
| 34 | regulation of postsynaptic membrane potential (GO:0060078) | 2.98534626 |
| 35 | central nervous system myelination (GO:0022010) | 2.98019532 |
| 36 | axon ensheathment in central nervous system (GO:0032291) | 2.98019532 |
| 37 | synaptic vesicle exocytosis (GO:0016079) | 2.96643785 |
| 38 | auditory behavior (GO:0031223) | 2.95457514 |
| 39 | vocalization behavior (GO:0071625) | 2.93185053 |
| 40 | clathrin coat assembly (GO:0048268) | 2.92940620 |
| 41 | regulation of synaptic plasticity (GO:0048167) | 2.92345358 |
| 42 | establishment of synaptic vesicle localization (GO:0097480) | 2.91171318 |
| 43 | synaptic vesicle transport (GO:0048489) | 2.91171318 |
| 44 | response to auditory stimulus (GO:0010996) | 2.89139786 |
| 45 | acidic amino acid transport (GO:0015800) | 2.88185140 |
| 46 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.82829528 |
| 47 | long-term synaptic potentiation (GO:0060291) | 2.82321440 |
| 48 | regulation of neurotransmitter transport (GO:0051588) | 2.81950840 |
| 49 | cellular sodium ion homeostasis (GO:0006883) | 2.81928042 |
| 50 | neuromuscular process controlling posture (GO:0050884) | 2.81668503 |
| 51 | potassium ion import (GO:0010107) | 2.78118993 |
| 52 | startle response (GO:0001964) | 2.77717364 |
| 53 | mitochondrion transport along microtubule (GO:0047497) | 2.76553580 |
| 54 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 2.76553580 |
| 55 | C4-dicarboxylate transport (GO:0015740) | 2.76207284 |
| 56 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.75492892 |
| 57 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.74819241 |
| 58 | long-term memory (GO:0007616) | 2.74301399 |
| 59 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 2.73291756 |
| 60 | positive regulation of neurotransmitter transport (GO:0051590) | 2.72159677 |
| 61 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.72082650 |
| 62 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.71822638 |
| 63 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.70076318 |
| 64 | establishment of vesicle localization (GO:0051650) | 2.68259696 |
| 65 | fatty acid elongation (GO:0030497) | 2.68039675 |
| 66 | protein localization to synapse (GO:0035418) | 2.67499065 |
| 67 | long-chain fatty acid biosynthetic process (GO:0042759) | 2.66031408 |
| 68 | regulation of synapse maturation (GO:0090128) | 2.64955105 |
| 69 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.64946001 |
| 70 | neurotransmitter uptake (GO:0001504) | 2.64645648 |
| 71 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.64051723 |
| 72 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.63801572 |
| 73 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.63560318 |
| 74 | axonal fasciculation (GO:0007413) | 2.63402966 |
| 75 | membrane hyperpolarization (GO:0060081) | 2.62229837 |
| 76 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.62104229 |
| 77 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.61406442 |
| 78 | dendritic spine morphogenesis (GO:0060997) | 2.60259397 |
| 79 | glycosphingolipid biosynthetic process (GO:0006688) | 2.59949727 |
| 80 | righting reflex (GO:0060013) | 2.59317129 |
| 81 | signal release (GO:0023061) | 2.58672858 |
| 82 | neuromuscular process controlling balance (GO:0050885) | 2.58495632 |
| 83 | glutamate secretion (GO:0014047) | 2.58167570 |
| 84 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.57994727 |
| 85 | gamma-aminobutyric acid transport (GO:0015812) | 2.57781316 |
| 86 | nerve growth factor signaling pathway (GO:0038180) | 2.55572395 |
| 87 | presynaptic membrane assembly (GO:0097105) | 2.53237456 |
| 88 | presynaptic membrane organization (GO:0097090) | 2.49969678 |
| 89 | proline transport (GO:0015824) | 2.46501100 |
| 90 | response to nerve growth factor (GO:1990089) | 2.45151634 |
| 91 | cellular response to nerve growth factor stimulus (GO:1990090) | 2.45151634 |
| 92 | cellular ketone body metabolic process (GO:0046950) | 2.43921662 |
| 93 | axon extension (GO:0048675) | 2.43225169 |
| 94 | locomotory exploration behavior (GO:0035641) | 2.42717815 |
| 95 | central nervous system projection neuron axonogenesis (GO:0021952) | 2.42164319 |
| 96 | regulation of synapse structural plasticity (GO:0051823) | 2.42162034 |
| 97 | cerebellar granule cell differentiation (GO:0021707) | 2.40628643 |
| 98 | organelle transport along microtubule (GO:0072384) | 2.39804034 |
| 99 | negative regulation of neurotransmitter transport (GO:0051589) | 2.39101551 |
| 100 | L-phenylalanine catabolic process (GO:0006559) | 2.38436630 |
| 101 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.38436630 |
| 102 | response to lipoprotein particle (GO:0055094) | 2.37695704 |
| 103 | cerebral cortex radially oriented cell migration (GO:0021799) | 2.36548695 |
| 104 | neuron remodeling (GO:0016322) | 2.34408716 |
| 105 | glutamate receptor signaling pathway (GO:0007215) | 2.33875041 |
| 106 | negative regulation of neurotransmitter secretion (GO:0046929) | 2.32487028 |
| 107 | regulation of synaptic vesicle transport (GO:1902803) | 2.31194567 |
| 108 | exploration behavior (GO:0035640) | 2.28746137 |
| 109 | cell migration in hindbrain (GO:0021535) | 2.28219386 |
| 110 | neuron projection extension (GO:1990138) | 2.24184108 |
| 111 | protein localization to endosome (GO:0036010) | 2.21597597 |
| 112 | positive regulation of filopodium assembly (GO:0051491) | 2.21380610 |
| 113 | neurotransmitter secretion (GO:0007269) | 2.20229667 |
| 114 | macroautophagy (GO:0016236) | 2.18896328 |
| 115 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.16042873 |
| 116 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.16042873 |
| 117 | modulation by symbiont of host immune response (GO:0052553) | 2.16042873 |
| 118 | positive regulation by symbiont of host defense response (GO:0052509) | 2.16042873 |
| 119 | modulation by symbiont of host defense response (GO:0052031) | 2.16042873 |
| 120 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.16042873 |
| 121 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.15484605 |
| 122 | apical protein localization (GO:0045176) | 2.12395105 |
| 123 | vesicle transport along microtubule (GO:0047496) | 2.11958411 |
| 124 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 2.11070787 |
| 125 | semaphorin-plexin signaling pathway (GO:0071526) | 2.11036231 |
| 126 | postsynaptic membrane organization (GO:0001941) | 2.11016167 |
| 127 | adult walking behavior (GO:0007628) | 2.09637144 |
| 128 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.08978829 |
| 129 | cholesterol efflux (GO:0033344) | 2.07678732 |
| 130 | regulation of filopodium assembly (GO:0051489) | 2.06427268 |
| 131 | synapse assembly (GO:0007416) | 2.05589051 |
| 132 | L-phenylalanine metabolic process (GO:0006558) | 2.05414018 |
| 133 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.05414018 |
| 134 | ketone body metabolic process (GO:1902224) | 2.04938432 |
| 135 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.04425729 |
| 136 | plasma lipoprotein particle clearance (GO:0034381) | 2.04362398 |
| 137 | central nervous system neuron axonogenesis (GO:0021955) | 2.03579960 |
| 138 | phagosome maturation (GO:0090382) | 2.02623373 |
| 139 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.01582686 |
| 140 | transmission of nerve impulse (GO:0019226) | 2.01402942 |
| 141 | regulation of dendritic spine development (GO:0060998) | 2.00628389 |
| 142 | mating behavior (GO:0007617) | 1.99875129 |
| 143 | synaptic vesicle endocytosis (GO:0048488) | 1.99838400 |
| 144 | ensheathment of neurons (GO:0007272) | 1.99231126 |
| 145 | axon ensheathment (GO:0008366) | 1.99231126 |
| 146 | synaptic transmission, glutamatergic (GO:0035249) | 1.98553239 |
| 147 | glycine transport (GO:0015816) | 1.97997193 |
| 148 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 1.97908268 |
| 149 | negative regulation of axonogenesis (GO:0050771) | 1.96288020 |
| 150 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 1.96190642 |
| 151 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 1.96190642 |
| 152 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 1.95940590 |
| 153 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 1.95635268 |
| 154 | protein carboxylation (GO:0018214) | 1.95137234 |
| 155 | peptidyl-glutamic acid carboxylation (GO:0017187) | 1.95137234 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.82708647 |
| 2 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.76774568 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.10519327 |
| 4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.97192476 |
| 5 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.93327712 |
| 6 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.91126027 |
| 7 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.85563679 |
| 8 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.84705076 |
| 9 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.79982960 |
| 10 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.76403946 |
| 11 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.73354276 |
| 12 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.70191948 |
| 13 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.68637867 |
| 14 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.65953670 |
| 15 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.65158112 |
| 16 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.64474934 |
| 17 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.64474934 |
| 18 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.63473398 |
| 19 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.62397787 |
| 20 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.60961745 |
| 21 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.59944039 |
| 22 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.58104974 |
| 23 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.56760516 |
| 24 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.56680583 |
| 25 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.56246913 |
| 26 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.54917187 |
| 27 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.53808328 |
| 28 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.51635734 |
| 29 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.49574489 |
| 30 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.49161904 |
| 31 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.48281373 |
| 32 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.47681782 |
| 33 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.42904590 |
| 34 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.40748732 |
| 35 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.37475452 |
| 36 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.36849406 |
| 37 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.36597676 |
| 38 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.34620350 |
| 39 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.34159963 |
| 40 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.33778307 |
| 41 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.33537773 |
| 42 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.33149580 |
| 43 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.29895304 |
| 44 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.28872583 |
| 45 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.28689680 |
| 46 | FUS_26573619_Chip-Seq_HEK293_Human | 1.27069346 |
| 47 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.26931699 |
| 48 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.26745404 |
| 49 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.26561380 |
| 50 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.26276939 |
| 51 | P300_19829295_ChIP-Seq_ESCs_Human | 1.24889451 |
| 52 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.24218979 |
| 53 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.23375683 |
| 54 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.23352941 |
| 55 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.23277935 |
| 56 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.23113443 |
| 57 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.23113443 |
| 58 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.22984350 |
| 59 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.22718591 |
| 60 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.21084176 |
| 61 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.19661276 |
| 62 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.19324010 |
| 63 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.18991927 |
| 64 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.18708851 |
| 65 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.17544580 |
| 66 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.17544580 |
| 67 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.17085154 |
| 68 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.17083563 |
| 69 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.14561420 |
| 70 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.14350257 |
| 71 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.13131188 |
| 72 | STAT3_23295773_ChIP-Seq_U87_Human | 1.13080929 |
| 73 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.12579941 |
| 74 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.12281140 |
| 75 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.11894795 |
| 76 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.11815839 |
| 77 | AR_25329375_ChIP-Seq_VCAP_Human | 1.11504908 |
| 78 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.10256171 |
| 79 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.08937866 |
| 80 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.08542045 |
| 81 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.07915286 |
| 82 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.07514356 |
| 83 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.07243482 |
| 84 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.06448847 |
| 85 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.05385143 |
| 86 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.05243050 |
| 87 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.04638490 |
| 88 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.04406778 |
| 89 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.04265657 |
| 90 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.03914288 |
| 91 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.02130443 |
| 92 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.02114834 |
| 93 | TP53_16413492_ChIP-PET_HCT116_Human | 1.01340077 |
| 94 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.00869554 |
| 95 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.00725872 |
| 96 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.00647631 |
| 97 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.99159952 |
| 98 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.98796055 |
| 99 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.98307514 |
| 100 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.97435667 |
| 101 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.97311572 |
| 102 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.97141098 |
| 103 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.96901571 |
| 104 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.96276466 |
| 105 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.95799113 |
| 106 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.95710051 |
| 107 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.95654400 |
| 108 | TCF4_23295773_ChIP-Seq_U87_Human | 0.95062037 |
| 109 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.94695579 |
| 110 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.94237360 |
| 111 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.93002721 |
| 112 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.92874962 |
| 113 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.91772890 |
| 114 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.91621920 |
| 115 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.91574945 |
| 116 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.89736076 |
| 117 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.89466893 |
| 118 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.89078386 |
| 119 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.88973050 |
| 120 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.87294026 |
| 121 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.86815153 |
| 122 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.86183814 |
| 123 | KDM2B_26808549_Chip-Seq_REH_Human | 0.85668242 |
| 124 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.85648887 |
| 125 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.85196338 |
| 126 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.84933840 |
| 127 | AR_19668381_ChIP-Seq_PC3_Human | 0.84575377 |
| 128 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.83866907 |
| 129 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.83332626 |
| 130 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.83274608 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 3.83195648 |
| 2 | MP0004270_analgesia | 3.33380346 |
| 3 | MP0003880_abnormal_central_pattern | 3.02937925 |
| 4 | MP0003329_amyloid_beta_deposits | 2.68886136 |
| 5 | MP0000604_amyloidosis | 2.58090063 |
| 6 | MP0003635_abnormal_synaptic_transmissio | 2.54544732 |
| 7 | MP0000920_abnormal_myelination | 2.51308594 |
| 8 | MP0003787_abnormal_imprinting | 2.49511528 |
| 9 | MP0002139_abnormal_hepatobiliary_system | 2.44920818 |
| 10 | MP0003303_peritoneal_inflammation | 2.42477505 |
| 11 | MP0003690_abnormal_glial_cell | 2.37712519 |
| 12 | MP0005423_abnormal_somatic_nervous | 2.32939314 |
| 13 | MP0002063_abnormal_learning/memory/cond | 2.24620811 |
| 14 | MP0003122_maternal_imprinting | 2.21658615 |
| 15 | MP0000778_abnormal_nervous_system | 2.20305378 |
| 16 | MP0002734_abnormal_mechanical_nocicepti | 2.10719004 |
| 17 | MP0005646_abnormal_pituitary_gland | 2.08273465 |
| 18 | MP0002064_seizures | 2.07774254 |
| 19 | MP0000569_abnormal_digit_pigmentation | 2.04550705 |
| 20 | MP0001984_abnormal_olfaction | 2.01521490 |
| 21 | MP0009745_abnormal_behavioral_response | 2.00999570 |
| 22 | MP0005360_urolithiasis | 1.97435787 |
| 23 | MP0009046_muscle_twitch | 1.97053218 |
| 24 | MP0009780_abnormal_chondrocyte_physiolo | 1.87465383 |
| 25 | MP0002735_abnormal_chemical_nociception | 1.84105423 |
| 26 | MP0002572_abnormal_emotion/affect_behav | 1.83070747 |
| 27 | MP0001486_abnormal_startle_reflex | 1.81526218 |
| 28 | MP0001968_abnormal_touch/_nociception | 1.81366062 |
| 29 | MP0002733_abnormal_thermal_nociception | 1.76718591 |
| 30 | MP0005058_abnormal_lysosome_morphology | 1.74663566 |
| 31 | MP0001440_abnormal_grooming_behavior | 1.74300493 |
| 32 | MP0003879_abnormal_hair_cell | 1.64567642 |
| 33 | MP0003634_abnormal_glial_cell | 1.64304557 |
| 34 | MP0004742_abnormal_vestibular_system | 1.62386671 |
| 35 | MP0004885_abnormal_endolymph | 1.60824766 |
| 36 | MP0005365_abnormal_bile_salt | 1.60181745 |
| 37 | MP0002272_abnormal_nervous_system | 1.57187841 |
| 38 | MP0003123_paternal_imprinting | 1.55536396 |
| 39 | MP0005085_abnormal_gallbladder_physiolo | 1.53645817 |
| 40 | MP0008875_abnormal_xenobiotic_pharmacok | 1.51007708 |
| 41 | MP0004510_myositis | 1.50852043 |
| 42 | MP0006082_CNS_inflammation | 1.48533318 |
| 43 | MP0003172_abnormal_lysosome_physiology | 1.46938528 |
| 44 | MP0001970_abnormal_pain_threshold | 1.43998200 |
| 45 | MP0004858_abnormal_nervous_system | 1.41126974 |
| 46 | MP0002184_abnormal_innervation | 1.40776511 |
| 47 | MP0001501_abnormal_sleep_pattern | 1.38614265 |
| 48 | MP0005551_abnormal_eye_electrophysiolog | 1.38232239 |
| 49 | MP0003195_calcinosis | 1.37630982 |
| 50 | MP0002067_abnormal_sensory_capabilities | 1.33342167 |
| 51 | MP0005386_behavior/neurological_phenoty | 1.33041516 |
| 52 | MP0004924_abnormal_behavior | 1.33041516 |
| 53 | MP0003632_abnormal_nervous_system | 1.32977125 |
| 54 | MP0003121_genomic_imprinting | 1.32696968 |
| 55 | MP0004811_abnormal_neuron_physiology | 1.30111330 |
| 56 | MP0002736_abnormal_nociception_after | 1.29657367 |
| 57 | MP0005083_abnormal_biliary_tract | 1.29498519 |
| 58 | MP0009840_abnormal_foam_cell | 1.27868713 |
| 59 | MP0003633_abnormal_nervous_system | 1.27805409 |
| 60 | MP0001529_abnormal_vocalization | 1.27305181 |
| 61 | MP0008877_abnormal_DNA_methylation | 1.24544692 |
| 62 | MP0000955_abnormal_spinal_cord | 1.24365625 |
| 63 | MP0002090_abnormal_vision | 1.24171005 |
| 64 | MP0003631_nervous_system_phenotype | 1.23045042 |
| 65 | MP0003075_altered_response_to | 1.22345143 |
| 66 | MP0002229_neurodegeneration | 1.19980448 |
| 67 | MP0006276_abnormal_autonomic_nervous | 1.19379060 |
| 68 | MP0010386_abnormal_urinary_bladder | 1.18762815 |
| 69 | MP0010329_abnormal_lipoprotein_level | 1.18356949 |
| 70 | MP0002557_abnormal_social/conspecific_i | 1.18177957 |
| 71 | MP0002138_abnormal_hepatobiliary_system | 1.15937152 |
| 72 | MP0005645_abnormal_hypothalamus_physiol | 1.14747513 |
| 73 | MP0002882_abnormal_neuron_morphology | 1.12882927 |
| 74 | MP0004130_abnormal_muscle_cell | 1.10179902 |
| 75 | MP0003191_abnormal_cellular_cholesterol | 1.09403484 |
| 76 | MP0002066_abnormal_motor_capabilities/c | 1.05483200 |
| 77 | MP0002118_abnormal_lipid_homeostasis | 1.04298017 |
| 78 | MP0002909_abnormal_adrenal_gland | 1.01891405 |
| 79 | MP0003183_abnormal_peptide_metabolism | 1.01815954 |
| 80 | MP0003252_abnormal_bile_duct | 1.01619122 |
| 81 | MP0001502_abnormal_circadian_rhythm | 0.96435716 |
| 82 | MP0005187_abnormal_penis_morphology | 0.95781376 |
| 83 | MP0005535_abnormal_body_temperature | 0.95763260 |
| 84 | MP0008260_abnormal_autophagy | 0.94759062 |
| 85 | MP0002254_reproductive_system_inflammat | 0.91898258 |
| 86 | MP0000383_abnormal_hair_follicle | 0.91624344 |
| 87 | MP0005166_decreased_susceptibility_to | 0.89961889 |
| 88 | MP0001348_abnormal_lacrimal_gland | 0.87325597 |
| 89 | MP0002876_abnormal_thyroid_physiology | 0.87151146 |
| 90 | MP0001485_abnormal_pinna_reflex | 0.86627856 |
| 91 | MP0010234_abnormal_vibrissa_follicle | 0.86361040 |
| 92 | MP0010678_abnormal_skin_adnexa | 0.85724402 |
| 93 | MP0000427_abnormal_hair_cycle | 0.83738197 |
| 94 | MP0002638_abnormal_pupillary_reflex | 0.82762003 |
| 95 | MP0002419_abnormal_innate_immunity | 0.82703395 |
| 96 | MP0001905_abnormal_dopamine_level | 0.82574865 |
| 97 | MP0005310_abnormal_salivary_gland | 0.82424500 |
| 98 | MP0008569_lethality_at_weaning | 0.82237203 |
| 99 | MP0001986_abnormal_taste_sensitivity | 0.81813161 |
| 100 | MP0000631_abnormal_neuroendocrine_gland | 0.81247769 |
| 101 | MP0001666_abnormal_nutrient_absorption | 0.79395270 |
| 102 | MP0005248_abnormal_Harderian_gland | 0.79346670 |
| 103 | MP0002752_abnormal_somatic_nervous | 0.78943387 |
| 104 | MP0005451_abnormal_body_composition | 0.77324954 |
| 105 | MP0004142_abnormal_muscle_tone | 0.76495427 |
| 106 | MP0001188_hyperpigmentation | 0.76162707 |
| 107 | MP0000579_abnormal_nail_morphology | 0.75767026 |
| 108 | MP0008874_decreased_physiological_sensi | 0.74834833 |
| 109 | MP0009764_decreased_sensitivity_to | 0.73467045 |
| 110 | MP0000647_abnormal_sebaceous_gland | 0.73373689 |
| 111 | MP0003868_abnormal_feces_composition | 0.73219047 |
| 112 | MP0002069_abnormal_eating/drinking_beha | 0.73002019 |
| 113 | MP0004043_abnormal_pH_regulation | 0.72660776 |
| 114 | MP0003656_abnormal_erythrocyte_physiolo | 0.72155586 |
| 115 | MP0008872_abnormal_physiological_respon | 0.69577875 |
| 116 | MP0000566_synostosis | 0.69391200 |
| 117 | MP0001963_abnormal_hearing_physiology | 0.69327738 |
| 118 | MP0001177_atelectasis | 0.69171263 |
| 119 | MP0002152_abnormal_brain_morphology | 0.68717457 |
| 120 | MP0002822_catalepsy | 0.68156384 |
| 121 | MP0002148_abnormal_hypersensitivity_rea | 0.67302816 |
| 122 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.66112686 |
| 123 | MP0005253_abnormal_eye_physiology | 0.64704234 |
| 124 | MP0000639_abnormal_adrenal_gland | 0.60964435 |
| 125 | MP0005167_abnormal_blood-brain_barrier | 0.60519459 |
| 126 | MP0001299_abnormal_eye_distance/ | 0.60294985 |
| 127 | MP0003938_abnormal_ear_development | 0.58612010 |
| 128 | MP0003861_abnormal_nervous_system | 0.55930254 |
| 129 | MP0005379_endocrine/exocrine_gland_phen | 0.55199892 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Neurofibrillary tangles (HP:0002185) | 5.52440963 |
| 2 | Cerebral inclusion bodies (HP:0100314) | 4.77274532 |
| 3 | Supranuclear gaze palsy (HP:0000605) | 4.69785670 |
| 4 | Febrile seizures (HP:0002373) | 4.29815385 |
| 5 | Mutism (HP:0002300) | 4.18165781 |
| 6 | Termporal pattern (HP:0011008) | 3.98182839 |
| 7 | Insidious onset (HP:0003587) | 3.98182839 |
| 8 | Atonic seizures (HP:0010819) | 3.96487396 |
| 9 | Abnormality of the corticospinal tract (HP:0002492) | 3.95710428 |
| 10 | Akinesia (HP:0002304) | 3.53026321 |
| 11 | Myokymia (HP:0002411) | 3.32182170 |
| 12 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 3.28384748 |
| 13 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 3.28384748 |
| 14 | Disinhibition (HP:0000734) | 3.27287986 |
| 15 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.19927831 |
| 16 | Ankle clonus (HP:0011448) | 3.19817300 |
| 17 | Increased cerebral lipofuscin (HP:0011813) | 3.11232185 |
| 18 | Epidermoid cyst (HP:0200040) | 2.96693201 |
| 19 | Absence seizures (HP:0002121) | 2.94157096 |
| 20 | Onion bulb formation (HP:0003383) | 2.93451386 |
| 21 | Action tremor (HP:0002345) | 2.92623285 |
| 22 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.90707363 |
| 23 | Spastic tetraparesis (HP:0001285) | 2.89564736 |
| 24 | Limb dystonia (HP:0002451) | 2.83043988 |
| 25 | Inappropriate behavior (HP:0000719) | 2.80859512 |
| 26 | Axonal loss (HP:0003447) | 2.78935548 |
| 27 | Drooling (HP:0002307) | 2.78458273 |
| 28 | Excessive salivation (HP:0003781) | 2.78458273 |
| 29 | Focal motor seizures (HP:0011153) | 2.73556313 |
| 30 | Neuronal loss in central nervous system (HP:0002529) | 2.71914016 |
| 31 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.70350662 |
| 32 | Ulnar claw (HP:0001178) | 2.67783764 |
| 33 | Apathy (HP:0000741) | 2.66652730 |
| 34 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.65964871 |
| 35 | Spastic gait (HP:0002064) | 2.65896630 |
| 36 | Focal seizures (HP:0007359) | 2.63612955 |
| 37 | Status epilepticus (HP:0002133) | 2.63216392 |
| 38 | Visual hallucinations (HP:0002367) | 2.63091923 |
| 39 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.61337408 |
| 40 | Peripheral demyelination (HP:0011096) | 2.59975878 |
| 41 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.58355526 |
| 42 | Hemiparesis (HP:0001269) | 2.56864315 |
| 43 | Amyotrophic lateral sclerosis (HP:0007354) | 2.56464401 |
| 44 | Hyperventilation (HP:0002883) | 2.54282352 |
| 45 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.52233814 |
| 46 | Polyphagia (HP:0002591) | 2.51625422 |
| 47 | Gaze-evoked nystagmus (HP:0000640) | 2.48432100 |
| 48 | Peripheral hypomyelination (HP:0007182) | 2.47456486 |
| 49 | Progressive inability to walk (HP:0002505) | 2.44770695 |
| 50 | Scanning speech (HP:0002168) | 2.40045794 |
| 51 | Truncal ataxia (HP:0002078) | 2.39515992 |
| 52 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.38501364 |
| 53 | Dysdiadochokinesis (HP:0002075) | 2.36798597 |
| 54 | Diminished motivation (HP:0000745) | 2.36486824 |
| 55 | Epileptic encephalopathy (HP:0200134) | 2.36139443 |
| 56 | Deep venous thrombosis (HP:0002625) | 2.35368883 |
| 57 | Increased circulating renin level (HP:0000848) | 2.33788145 |
| 58 | Systemic lupus erythematosus (HP:0002725) | 2.29924808 |
| 59 | Intrahepatic cholestasis (HP:0001406) | 2.28389315 |
| 60 | Pheochromocytoma (HP:0002666) | 2.26111832 |
| 61 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.25143395 |
| 62 | Intention tremor (HP:0002080) | 2.24122330 |
| 63 | Torticollis (HP:0000473) | 2.24112032 |
| 64 | Cerebral hypomyelination (HP:0006808) | 2.22499514 |
| 65 | Agitation (HP:0000713) | 2.21647380 |
| 66 | Postural instability (HP:0002172) | 2.21028233 |
| 67 | Eczematoid dermatitis (HP:0000976) | 2.20480517 |
| 68 | Delusions (HP:0000746) | 2.18438068 |
| 69 | Xanthomatosis (HP:0000991) | 2.18315199 |
| 70 | Loss of speech (HP:0002371) | 2.18205794 |
| 71 | Generalized tonic-clonic seizures (HP:0002069) | 2.18105138 |
| 72 | Complement deficiency (HP:0004431) | 2.18073941 |
| 73 | Recurrent bacterial skin infections (HP:0005406) | 2.17105707 |
| 74 | Urinary urgency (HP:0000012) | 2.16508659 |
| 75 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.16491955 |
| 76 | Abnormality of glycolipid metabolism (HP:0010969) | 2.16491955 |
| 77 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.16491955 |
| 78 | Abnormality of binocular vision (HP:0011514) | 2.15878755 |
| 79 | Diplopia (HP:0000651) | 2.15878755 |
| 80 | Broad-based gait (HP:0002136) | 2.15730985 |
| 81 | Muscular hypotonia of the trunk (HP:0008936) | 2.14935224 |
| 82 | Anxiety (HP:0000739) | 2.14781371 |
| 83 | Dysostosis multiplex (HP:0000943) | 2.14299161 |
| 84 | Depression (HP:0000716) | 2.13749457 |
| 85 | Clumsiness (HP:0002312) | 2.11014759 |
| 86 | Papillary thyroid carcinoma (HP:0002895) | 2.10669948 |
| 87 | Gait imbalance (HP:0002141) | 2.10385443 |
| 88 | Slow saccadic eye movements (HP:0000514) | 2.10152519 |
| 89 | Spastic tetraplegia (HP:0002510) | 2.09245266 |
| 90 | Papilledema (HP:0001085) | 2.08026111 |
| 91 | Lower limb muscle weakness (HP:0007340) | 2.06389362 |
| 92 | Dysmetria (HP:0001310) | 2.06134663 |
| 93 | Amblyopia (HP:0000646) | 2.04404403 |
| 94 | Poor eye contact (HP:0000817) | 2.03736427 |
| 95 | Progressive cerebellar ataxia (HP:0002073) | 2.03659343 |
| 96 | Vacuolated lymphocytes (HP:0001922) | 2.02485506 |
| 97 | Parakeratosis (HP:0001036) | 2.01839464 |
| 98 | Amyloidosis (HP:0011034) | 2.01621673 |
| 99 | Cortical dysplasia (HP:0002539) | 2.01457155 |
| 100 | Abnormality of salivation (HP:0100755) | 1.99830988 |
| 101 | Impaired vibratory sensation (HP:0002495) | 1.99203154 |
| 102 | Generalized myoclonic seizures (HP:0002123) | 1.98866228 |
| 103 | Pachygyria (HP:0001302) | 1.98308368 |
| 104 | Retinal atrophy (HP:0001105) | 1.96798145 |
| 105 | Decreased motor nerve conduction velocity (HP:0003431) | 1.96476636 |
| 106 | Recurrent abscess formation (HP:0002722) | 1.93999522 |
| 107 | Neuroendocrine neoplasm (HP:0100634) | 1.92629144 |
| 108 | Hyperlipoproteinemia (HP:0010980) | 1.92306558 |
| 109 | Abnormality of macrophages (HP:0004311) | 1.90673191 |
| 110 | Abnormal eating behavior (HP:0100738) | 1.90095162 |
| 111 | Postural tremor (HP:0002174) | 1.90074300 |
| 112 | EEG with generalized epileptiform discharges (HP:0011198) | 1.89299465 |
| 113 | Hypsarrhythmia (HP:0002521) | 1.88924362 |
| 114 | Paraplegia (HP:0010550) | 1.88660579 |
| 115 | Abnormality of the periventricular white matter (HP:0002518) | 1.88091814 |
| 116 | Macroorchidism (HP:0000053) | 1.86565147 |
| 117 | Focal dystonia (HP:0004373) | 1.85640798 |
| 118 | Prolonged partial thromboplastin time (HP:0003645) | 1.85526921 |
| 119 | Bradykinesia (HP:0002067) | 1.85482569 |
| 120 | Diminished movement (HP:0002374) | 1.84978519 |
| 121 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.84687401 |
| 122 | Split foot (HP:0001839) | 1.84472287 |
| 123 | Epileptiform EEG discharges (HP:0011182) | 1.84332980 |
| 124 | Cerebral hemorrhage (HP:0001342) | 1.84099752 |
| 125 | Choreoathetosis (HP:0001266) | 1.83699361 |
| 126 | Dialeptic seizures (HP:0011146) | 1.83400617 |
| 127 | Craniofacial dystonia (HP:0012179) | 1.83149611 |
| 128 | Clonus (HP:0002169) | 1.81359353 |
| 129 | Hypoplasia of the corpus callosum (HP:0002079) | 1.79580403 |
| 130 | Abnormal social behavior (HP:0012433) | 1.79393944 |
| 131 | Impaired social interactions (HP:0000735) | 1.79393944 |
| 132 | Alacrima (HP:0000522) | 1.79386458 |
| 133 | Hepatoblastoma (HP:0002884) | 1.78804023 |
| 134 | Mucopolysacchariduria (HP:0008155) | 1.78204720 |
| 135 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.78204720 |
| 136 | Absent speech (HP:0001344) | 1.78120521 |
| 137 | Hammertoe (HP:0001765) | 1.77784542 |
| 138 | Tetraplegia (HP:0002445) | 1.75077736 |
| 139 | Dyskinesia (HP:0100660) | 1.72104664 |
| 140 | Spastic paraplegia (HP:0001258) | 1.68224964 |
| 141 | Gait ataxia (HP:0002066) | 1.68135908 |
| 142 | Abnormality of ocular smooth pursuit (HP:0000617) | 1.65529502 |
| 143 | Impaired smooth pursuit (HP:0007772) | 1.64266921 |
| 144 | Sleep apnea (HP:0010535) | 1.63320576 |
| 145 | Abnormality of the lower motor neuron (HP:0002366) | 1.62796565 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MARK1 | 6.23135916 |
| 2 | MAP3K9 | 2.66162261 |
| 3 | DAPK2 | 2.22856256 |
| 4 | STK39 | 2.18663830 |
| 5 | PKN1 | 2.14103751 |
| 6 | DYRK2 | 2.07599269 |
| 7 | MAP3K4 | 1.91982094 |
| 8 | CASK | 1.82969459 |
| 9 | NTRK2 | 1.76917356 |
| 10 | PRKD3 | 1.72589558 |
| 11 | RIPK4 | 1.70711760 |
| 12 | FGR | 1.65960387 |
| 13 | SIK2 | 1.63119540 |
| 14 | NTRK3 | 1.62710434 |
| 15 | PHKG2 | 1.59002885 |
| 16 | PHKG1 | 1.59002885 |
| 17 | MINK1 | 1.57488728 |
| 18 | EPHA4 | 1.57171933 |
| 19 | PAK6 | 1.50363307 |
| 20 | EPHB1 | 1.48146223 |
| 21 | MAPK13 | 1.46602115 |
| 22 | OXSR1 | 1.41311864 |
| 23 | MAP4K2 | 1.40527309 |
| 24 | NTRK1 | 1.40043237 |
| 25 | PBK | 1.38534203 |
| 26 | MAP2K7 | 1.36131032 |
| 27 | CSNK1G2 | 1.34549518 |
| 28 | MAP3K2 | 1.32977644 |
| 29 | KSR2 | 1.31780666 |
| 30 | TAOK3 | 1.27459717 |
| 31 | BLK | 1.25375780 |
| 32 | CDK5 | 1.22267039 |
| 33 | MAP2K4 | 1.21210629 |
| 34 | LIMK1 | 1.20787443 |
| 35 | PINK1 | 1.18007087 |
| 36 | SGK2 | 1.16605841 |
| 37 | ERBB4 | 1.16219147 |
| 38 | WNK3 | 1.15559359 |
| 39 | BCR | 1.11746460 |
| 40 | MAP3K14 | 1.10588720 |
| 41 | TRIM28 | 1.09971268 |
| 42 | ERBB3 | 1.09956646 |
| 43 | MST1R | 1.04261421 |
| 44 | CSNK1A1L | 1.03567316 |
| 45 | PRPF4B | 1.03352241 |
| 46 | LMTK2 | 1.02739935 |
| 47 | PLK2 | 1.01915200 |
| 48 | MARK2 | 0.97251187 |
| 49 | RET | 0.97233575 |
| 50 | CAMK1G | 0.96997301 |
| 51 | CSNK1G3 | 0.95406578 |
| 52 | CAMKK1 | 0.92206967 |
| 53 | ABL2 | 0.90454793 |
| 54 | PRKCZ | 0.90124297 |
| 55 | DAPK1 | 0.88350406 |
| 56 | INSRR | 0.86241082 |
| 57 | NEK6 | 0.85521747 |
| 58 | PAK3 | 0.85063840 |
| 59 | UHMK1 | 0.84957875 |
| 60 | SGK494 | 0.83766608 |
| 61 | SGK223 | 0.83766608 |
| 62 | PRKCE | 0.83639754 |
| 63 | BMPR1B | 0.83597029 |
| 64 | MAP3K13 | 0.82899407 |
| 65 | CAMK1 | 0.81961788 |
| 66 | SGK3 | 0.81191475 |
| 67 | STK38 | 0.80084808 |
| 68 | LATS2 | 0.79998926 |
| 69 | CAMK2A | 0.79797796 |
| 70 | CAMK2B | 0.78413124 |
| 71 | FYN | 0.78067388 |
| 72 | WNK4 | 0.77349346 |
| 73 | MET | 0.76196964 |
| 74 | CDK11A | 0.72699849 |
| 75 | GRK5 | 0.71853596 |
| 76 | FGFR2 | 0.70183870 |
| 77 | FES | 0.68146429 |
| 78 | KSR1 | 0.67926592 |
| 79 | MAPK10 | 0.67848344 |
| 80 | DYRK1A | 0.67041758 |
| 81 | MAP3K6 | 0.66653819 |
| 82 | STK11 | 0.66580051 |
| 83 | TYRO3 | 0.66076861 |
| 84 | CSNK1G1 | 0.65551152 |
| 85 | BMPR2 | 0.65475258 |
| 86 | AKT3 | 0.64067865 |
| 87 | RPS6KA2 | 0.63604557 |
| 88 | PDPK1 | 0.61485277 |
| 89 | YES1 | 0.60385196 |
| 90 | PNCK | 0.59570935 |
| 91 | ROCK2 | 0.58955147 |
| 92 | STK38L | 0.58936772 |
| 93 | FER | 0.58644720 |
| 94 | MAP3K12 | 0.58527118 |
| 95 | SGK1 | 0.57337716 |
| 96 | TBK1 | 0.56789599 |
| 97 | CDK14 | 0.56531497 |
| 98 | CAMK4 | 0.56439321 |
| 99 | CSNK1A1 | 0.55867431 |
| 100 | GSK3A | 0.55099899 |
| 101 | PRKCG | 0.54831144 |
| 102 | PRKCH | 0.54020794 |
| 103 | BMX | 0.52364073 |
| 104 | RIPK1 | 0.52255158 |
| 105 | PRKCQ | 0.51948241 |
| 106 | CSNK1D | 0.51791022 |
| 107 | WNK1 | 0.51705120 |
| 108 | CSNK1E | 0.51609228 |
| 109 | RPS6KA3 | 0.51591821 |
| 110 | FRK | 0.48467620 |
| 111 | CDK19 | 0.48397301 |
| 112 | ALK | 0.48185744 |
| 113 | CAMK1D | 0.47776426 |
| 114 | CAMKK2 | 0.47614318 |
| 115 | EGFR | 0.44518883 |
| 116 | PIK3CA | 0.44287729 |
| 117 | CAMK2G | 0.44165280 |
| 118 | CDK15 | 0.43066246 |
| 119 | RPS6KB1 | 0.42928113 |
| 120 | MST4 | 0.42309353 |
| 121 | JAK2 | 0.42019166 |
| 122 | MAPK12 | 0.41834229 |
| 123 | CAMK2D | 0.41565641 |
| 124 | TNIK | 0.40879619 |
| 125 | JAK1 | 0.40877810 |
| 126 | CDK18 | 0.40614708 |
| 127 | ERBB2 | 0.40490816 |
| 128 | CCNB1 | 0.40123215 |
| 129 | PRKACB | 0.39806309 |
| 130 | PRKG1 | 0.39306013 |
| 131 | MAPKAPK5 | 0.39305574 |
| 132 | PDK1 | 0.39221965 |
| 133 | DAPK3 | 0.39160144 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.28940901 |
| 2 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.24284505 |
| 3 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.95338397 |
| 4 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.91932598 |
| 5 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.77992243 |
| 6 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.63915932 |
| 7 | Nicotine addiction_Homo sapiens_hsa05033 | 1.61676170 |
| 8 | GABAergic synapse_Homo sapiens_hsa04727 | 1.58134871 |
| 9 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.52576159 |
| 10 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.52379432 |
| 11 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.50207689 |
| 12 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.46270787 |
| 13 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.43286742 |
| 14 | Axon guidance_Homo sapiens_hsa04360 | 1.41628976 |
| 15 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.40398566 |
| 16 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.39939227 |
| 17 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.32853531 |
| 18 | Morphine addiction_Homo sapiens_hsa05032 | 1.28536131 |
| 19 | Phagosome_Homo sapiens_hsa04145 | 1.26468597 |
| 20 | Circadian rhythm_Homo sapiens_hsa04710 | 1.20039783 |
| 21 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.19537271 |
| 22 | Lysosome_Homo sapiens_hsa04142 | 1.19215233 |
| 23 | Circadian entrainment_Homo sapiens_hsa04713 | 1.18170287 |
| 24 | Histidine metabolism_Homo sapiens_hsa00340 | 1.17674270 |
| 25 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.15752497 |
| 26 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.14880212 |
| 27 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.11964242 |
| 28 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.09781094 |
| 29 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.08792031 |
| 30 | Cocaine addiction_Homo sapiens_hsa05030 | 1.08453981 |
| 31 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.04497484 |
| 32 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.04216576 |
| 33 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.03963472 |
| 34 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.01485918 |
| 35 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.01342263 |
| 36 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.01139685 |
| 37 | Prion diseases_Homo sapiens_hsa05020 | 1.00279774 |
| 38 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.99204334 |
| 39 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.97618189 |
| 40 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.94765950 |
| 41 | Long-term depression_Homo sapiens_hsa04730 | 0.93462775 |
| 42 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.93432847 |
| 43 | Renin secretion_Homo sapiens_hsa04924 | 0.90792545 |
| 44 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.89744510 |
| 45 | Phototransduction_Homo sapiens_hsa04744 | 0.89639301 |
| 46 | Olfactory transduction_Homo sapiens_hsa04740 | 0.87235574 |
| 47 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.86439997 |
| 48 | Long-term potentiation_Homo sapiens_hsa04720 | 0.85559587 |
| 49 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.84160770 |
| 50 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.84030304 |
| 51 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.83736182 |
| 52 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.83684325 |
| 53 | Salivary secretion_Homo sapiens_hsa04970 | 0.83489946 |
| 54 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.82624885 |
| 55 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.82378965 |
| 56 | Bile secretion_Homo sapiens_hsa04976 | 0.82183741 |
| 57 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.82131587 |
| 58 | Pertussis_Homo sapiens_hsa05133 | 0.81936064 |
| 59 | Mineral absorption_Homo sapiens_hsa04978 | 0.81851156 |
| 60 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.80443048 |
| 61 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.79567429 |
| 62 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.79384198 |
| 63 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.79383541 |
| 64 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.78645367 |
| 65 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.76977373 |
| 66 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.74446051 |
| 67 | Tuberculosis_Homo sapiens_hsa05152 | 0.74253402 |
| 68 | ABC transporters_Homo sapiens_hsa02010 | 0.72483079 |
| 69 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.72155217 |
| 70 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.70128232 |
| 71 | Insulin secretion_Homo sapiens_hsa04911 | 0.69579783 |
| 72 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.68541609 |
| 73 | Salmonella infection_Homo sapiens_hsa05132 | 0.68502251 |
| 74 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.68439482 |
| 75 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.67755723 |
| 76 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.67100699 |
| 77 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.66334015 |
| 78 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.65727014 |
| 79 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.65619212 |
| 80 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.65494175 |
| 81 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.64492199 |
| 82 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.63832305 |
| 83 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.62791300 |
| 84 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.60594386 |
| 85 | Protein export_Homo sapiens_hsa03060 | 0.60395557 |
| 86 | Gap junction_Homo sapiens_hsa04540 | 0.59976258 |
| 87 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.59874778 |
| 88 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.59280549 |
| 89 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.58627056 |
| 90 | Taste transduction_Homo sapiens_hsa04742 | 0.58484938 |
| 91 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.58258609 |
| 92 | Amoebiasis_Homo sapiens_hsa05146 | 0.58091994 |
| 93 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.57951219 |
| 94 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.57245559 |
| 95 | Endocytosis_Homo sapiens_hsa04144 | 0.56992282 |
| 96 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.56406037 |
| 97 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.56345259 |
| 98 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.55726868 |
| 99 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.55547229 |
| 100 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.55472854 |
| 101 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.54990341 |
| 102 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.53952217 |
| 103 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.51396962 |
| 104 | Melanogenesis_Homo sapiens_hsa04916 | 0.50473189 |
| 105 | Tight junction_Homo sapiens_hsa04530 | 0.49186123 |
| 106 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.48803677 |
| 107 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.48792983 |
| 108 | Leishmaniasis_Homo sapiens_hsa05140 | 0.48376163 |
| 109 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.48184794 |
| 110 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.47989967 |
| 111 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.47730190 |
| 112 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.47145354 |
| 113 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.47116772 |
| 114 | Peroxisome_Homo sapiens_hsa04146 | 0.46715786 |
| 115 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.46215722 |
| 116 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.45417674 |
| 117 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.45348687 |
| 118 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.45026454 |
| 119 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.44965526 |
| 120 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.44882504 |
| 121 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.44727319 |
| 122 | Glioma_Homo sapiens_hsa05214 | 0.44576737 |
| 123 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.41922296 |
| 124 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.41572720 |
| 125 | Endometrial cancer_Homo sapiens_hsa05213 | 0.41416963 |
| 126 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.40930707 |
| 127 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.38766562 |
| 128 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.38461380 |
| 129 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.38117522 |
| 130 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.33827018 |

